Currently, there are 71 clinical trials focusing on the effects of SIRT1 on various disorders, including vascular system injuries, coronary artery disease, aging, and type 2 diabetes [40,41]. The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.